docetaxel
Showing 1 - 7 of 7
Docetaxel, Solid Tumours, Bioequivalence Trial in Andra, Gujrat, Mahara (BH009 (Docetaxel injection), Docetaxel injection)
Completed
- Docetaxel
- +2 more
- BH009 (Docetaxel injection)
- Docetaxel injection
-
Andra, India
- +2 more
Dec 20, 2021
Addition of Docetaxel to Standard Treatment in First-line
Completed
- HER2-positive Gastric Cancer
- +3 more
-
Besançon, Franche-Comté, FranceCHU Besancon
Jun 4, 2021
Stomach Tumors, Gastrointestinal Tumors, Docetaxel Trial in Moscow (Irinotecan, 5-FU, Leucovorin)
Recruiting
- Stomach Neoplasms
- +5 more
- Irinotecan
- +4 more
-
Moscow, Russian FederationAleksei Kalinin
Apr 12, 2021
PROSTAC: Prospective Multi-centre Study of Prognostic Factors in
Unknown status
- Advanced Prostate Cancer
- +2 more
-
Santiago de Compostela, A Coruña, Spain
- +24 more
Jan 23, 2020
Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor
Unknown status
- Solid Tumors
- +4 more
- detection of genotype
-
Beijing, Beijing, China
- +5 more
Aug 27, 2019
NSCLC, Docetaxel, Nivolumab Trial in Beijing (Nivolumab)
Unknown status
- Carcinoma, Non-Small-Cell Lung
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jul 16, 2019
Lung Tumors, Docetaxel, Pemetrexed Trial in Lianyungang (anlotinib plus chemo, chemo)
Unknown status
- Lung Neoplasms
- +4 more
- anlotinib plus chemotherapy
- chemotherapy
-
Lianyungang, Jiangsu, ChinaThe Affiliated Lianyungang Hospital of Xuzhou Medical University
Jul 16, 2018